Table 3.
Outcomes | HR (95% CI) |
P-Value | Adjusted HR (95% CI)a |
P-Value | log-rank test | |
---|---|---|---|---|---|---|
χ2 | P-Value | |||||
ACM | 1.521 (1.007–2.299) | 0.046 | 2.042 (1.264–3.300) | 0.004 | 4.039 | 0.044 |
CM | 1.264 (0.762–2.094) | 0.364 | 1.707 (0.952–3.061) | 0.072 | 0.830 | 0.362 |
MACEs | 1.073 (0.857–1.344) | 0.540 | 1.143 (0.898–1.456) | 0.277 | 0.378 | 0.539 |
Heart failure | 1.912 (1.519–2.406) | < 0.001 | 1.700 (1.347–2.147) | < 0.001 | 32.172 | < 0.001 |
MACCEs | 0.973 (0.801–1.182) | 0.784 | 1.023 (0.832–1.260) | 0.827 | 0.076 | 0.783 |
Abbreviation: THR Triglyceride to high-density lipoprotein cholesterol ratio, ACM All-cause mortality, CM Cardiac mortality, MACEs Major Adverse cardiovascular events including cardiac death, bleeding events, readmission, MACCEs Major adverse cardiovascular and cerebrovascular events including MACEs and stroke. Note: The boldfaced P-Values are statistically different
aAdjusted for age, gender, family history, hypertension, diabetes, smoking, alcohol consumption, creatinine, uric acid, and total cholesterol